
Swastik Drugs Pvt Ltd
About Swastik Drugs Pvt Ltd
Data last updated:
Swastik Drugs Pvt Ltd is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 June 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U02421MP1988PTC004662. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Narendra Kumar Jain and Rakesh Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6/1 Sikh Mohalla, Indore, Madhya Pradesh, India – 452007.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.1 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹23,901 (net margin 5.8%) and EBITDA of ₹24,266 (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Swastik Drugs Pvt Ltd's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6/1 Sikh Mohalla, Indore, Madhya Pradesh, India – 452007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Swastik Drugs Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Swastik Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Swastik Drugs Pvt Ltd, buy the company report.
Financials of Swastik Drugs Pvt Ltd
FY 2025 filings availableSwastik Drugs Pvt Ltd reported revenue of ₹4.1 Lakh (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 17% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24,266 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23,901 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Swastik Drugs Pvt Ltd, buy the company report.
Board of directors of Swastik Drugs Pvt Ltd
Swastik Drugs has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Kumar Jain Also directs: Sunderlal Moolchand Jain Tobacconist Private Limited | Director | 17 Jun 1988 | 38 Years 5 Months | Current |
| Rakesh Jain | Director | 17 Jun 1988 | 38 Years 5 Months | Current |
| Azad Kumar Jain Also directs: Sunderlal Moolchand Jain Tobacconist Private Limited | Director | 17 Jun 1988 | 38 Years 5 Months | Current |
| Rajeev Jain Also directs: Inheart Gases Private Limited | Director | 16 Aug 2001 | 25 Years 3 Months | Current |
Peer comparison
Swastik Drugs Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Steeford Pharmaceuticals Private Limited | ₹4.16 Lakh (FY 2025) | 14.0% | Gorakhpur, Uttar Pradesh, India | |||
| G.K. Pharmaceuticals Pvt.Ltd. | ₹4.15 Lakh (FY 2022) | 63.0% | Telangana, India | |||
| Biokol Medical Private Limited | ₹4.14 Lakh (FY 2025) | -88.0% | New Delhi, Delhi, India | |||
| Swastik Drugs Pvt Ltdthis company | ₹4.1 Lakh (FY 2025) | ₹23,901 | 5.8% | -17.0% | Indore, Madhya Pradesh, India | |
| Baba Mohan Ram Pharma Private Limited | ₹4.08 Lakh (FY 2025) | -17.0% | Noida, Uttar Pradesh, India | |||
| Iwaantra Biological Private Limited | ₹4.06 Lakh (FY 2025) | -8.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Swastik Drugs Pvt Ltd, buy the company report.
Auditor
Swastik Drugs Pvt Ltd is audited by Prabhat Rathi & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Prabhat Rathi & Associates | FY 2023 | 009520C |
Shareholding
The shareholding of Swastik Drugs Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Swastik Drugs Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Swastik Drugs Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Swastik Drugs Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Swastik Drugs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Swastik Drugs Pvt Ltd, buy the company report.
Recent activity
Swastik Drugs Pvt Ltd has 4 board changes on record since 1988: 4 appointments. The latest: Rajeev Jain was appointed as Director on 16 Aug 2001.
Frequently asked questions
Swastik Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 June 1988 (38+ years old) and is registered under CIN U02421MP1988PTC004662.
Swastik Drugs has 4 current directors:
- Narendra Kumar Jain - Director
- Rakesh Jain - Director
- Azad Kumar Jain - Director
- Rajeev Jain - Director
The latest financial statements of Swastik Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Swastik Drugs has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Swastik Drugs is U02421MP1988PTC004662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swastik Drugs was incorporated on 17 June 1988, making it 38+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Swastik Drugs by revenue are Steeford Pharmaceuticals Private Limited, G.K. Pharmaceuticals Pvt.Ltd, Biokol Medical Private Limited, Baba Mohan Ram Pharma Private Limited, Iwaantra Biological Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rajeev Jain was appointed as Director on 16 Aug 2001. Azad Kumar Jain was appointed as Director on 17 Jun 1988. Narendra Kumar Jain was appointed as Director on 17 Jun 1988. Swastik Drugs has 4 board changes on record in total.
The registered office of Swastik Drugs is at 61 Sikh Mohalla, Indore, Madhya Pradesh, India – 452007.
Swastik Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Swastik Drugs is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.

